Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A DeFronzo

Showing results (31-40 of 355) with videos related to

Pageof 36
Sort By:
Endocrine Reviews|May 4, 2019
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing AgentsAntonino Di Pino, Ralph A DeFronzo
Diabetes Care|July 23, 2017
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes AlgorithmMuhammad Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 26, 2021
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?Muhammad Abdul-Ghani, Ralph A DeFronzo
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretionMuhammad Abdul-Ghani, Ralph A DeFronzo
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors and the KidneyRalph A DeFronzo, Muhammad Abdul-Ghani
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Fasting Hyperinsulinemia and Obesity: Cause or EffectMuhammad Abdul-Ghani, Ralph A DeFronzo
Current Pharmaceutical Biotechnology|December 24, 2015
Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult MiceBruno Doiron, Wenchao Hu, Ralph A DeFronzo
Diabetes Care|March 5, 2002
Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetesYoshinori Miyazaki, Masafumi Matsuda, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|June 27, 2013
Dapagliflozin for the treatment of type 2 diabetesMuhammad A Abdul-Ghani, Ralph A DeFronzo
The Journal of Clinical Endocrinology and Metabolism|June 24, 2011
Preservation of β-cell function: the key to diabetes preventionRalph A DeFronzo, Muhammad A Abdul-Ghani
Pageof 36

Showing results (31-40 of 355) with videos related to

Sort By:
Pageof 36
Endocrine Reviews|May 4, 2019
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing AgentsAntonino Di Pino, Ralph A DeFronzo
Diabetes Care|July 23, 2017
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes AlgorithmMuhammad Abdul-Ghani, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|August 26, 2021
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?Muhammad Abdul-Ghani, Ralph A DeFronzo
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretionMuhammad Abdul-Ghani, Ralph A DeFronzo
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors and the KidneyRalph A DeFronzo, Muhammad Abdul-Ghani
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Fasting Hyperinsulinemia and Obesity: Cause or EffectMuhammad Abdul-Ghani, Ralph A DeFronzo
Current Pharmaceutical Biotechnology|December 24, 2015
Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult MiceBruno Doiron, Wenchao Hu, Ralph A DeFronzo
Diabetes Care|March 5, 2002
Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetesYoshinori Miyazaki, Masafumi Matsuda, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|June 27, 2013
Dapagliflozin for the treatment of type 2 diabetesMuhammad A Abdul-Ghani, Ralph A DeFronzo
The Journal of Clinical Endocrinology and Metabolism|June 24, 2011
Preservation of β-cell function: the key to diabetes preventionRalph A DeFronzo, Muhammad A Abdul-Ghani
Pageof 36